0001104659-24-003435.txt : 20240111
0001104659-24-003435.hdr.sgml : 20240111
20240111200028
ACCESSION NUMBER: 0001104659-24-003435
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240109
FILED AS OF DATE: 20240111
DATE AS OF CHANGE: 20240111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Gupta Suneel
CENTRAL INDEX KEY: 0001763923
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37852
FILM NUMBER: 24530368
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Protagonist Therapeutics, Inc
CENTRAL INDEX KEY: 0001377121
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 980505495
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
BUSINESS PHONE: (510) 474-0170
MAIL ADDRESS:
STREET 1: 7707 GATEWAY BLVD., SUITE 140
CITY: NEWARK
STATE: CA
ZIP: 94560-1160
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Therapeutics Inc
DATE OF NAME CHANGE: 20130605
FORMER COMPANY:
FORMER CONFORMED NAME: Protagonist Inc
DATE OF NAME CHANGE: 20061002
4
1
tm243091-1_4seq1.xml
OWNERSHIP DOCUMENT
X0508
4
2024-01-09
0
0001377121
Protagonist Therapeutics, Inc
PTGX
0001763923
Gupta Suneel
C/O PROTAGONIST THERAPEUTICS, INC.
7707 GATEWAY BLVD., SUITE 140
NEWARK
CA
94560-1160
0
1
0
0
Chief Development Officer
1
Common Stock
2024-01-09
4
M
0
5000
7.38
A
192567
D
Common Stock
2024-01-09
4
S
0
5000
25.00
D
187567
D
Stock Option (right to buy)
7.38
2024-01-09
4
M
0
5000
0.00
D
2029-01-14
Common Stock
5000
45000
D
Sale of shares effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on April 25, 2023.
These stock options are fully vested.
/s/ Matthew Gosling, Attorney-in-Fact for Suneel Gupta
2024-01-11